Inventor
HUNG CHIEN-FU
US21 patents
⚠️ This page may combine multiple inventors who share the name “HUNG CHIEN-FU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV JOHNS HOPKINS
16 patentsUS7557200B2Jul 7, 2009
Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation
UNIV JOHNS HOPKINS55 citations97
US7342002B2Mar 11, 2008
Molecular vaccine linking an endoplasmic chaperone polypeptide to an antigen
UNIV JOHNS HOPKINS16 citations92
US6734173B1May 11, 2004
HSP DNA vaccines
UNIV JOHNS HOPKINS42 citations92
US7318928B2Jan 15, 2008
Molecular vaccine linking intercellular spreading protein to an antigen
UNIV JOHNS HOPKINS17 citations77
US10799579B2Oct 13, 2020
Methods for enhancing antigen-specific immune responses
UNIV JOHNS HOPKINS4 citations72
US10350282B2Jul 16, 2019
Mesothelin vaccines and model systems
UNIV JOHNS HOPKINS1 citations70
US11766478B2Sep 26, 2023
Methods for enhancing antigen-specific immune responses
UNIV JOHNS HOPKINS1 citations62
US8007781B2Aug 30, 2011
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
UNIV JOHNS HOPKINS4 citations62
US11285197B2Mar 29, 2022
Mesothelin vaccines and model systems
UNIV JOHNS HOPKINS0 citations59
US11987606B2May 21, 2024
Compositions and methods for enhancing an immune response
UNIV JOHNS HOPKINS0 citations57
US12357673B2Jul 15, 2025
Compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion proteins and uses thereof
UNIV JOHNS HOPKINS0 citations56
US12364980B2Jul 22, 2025
Non-invasive cancer detection and analysis by single-molecule imaging
UNIV JOHNS HOPKINS0 citations55
US11246908B2Feb 15, 2022
Compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion proteins and uses thereof
UNIV JOHNS HOPKINS0 citations54
US10183985B2Jan 22, 2019
Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
UNIV JOHNS HOPKINS0 citations49
US9561275B2Feb 7, 2017
Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
UNIV JOHNS HOPKINS0 citations49
US12434236B2Oct 7, 2025
Methods and materials for treating cancer
UNIV JOHNS HOPKINS0 citations46
WU TZYY-CHOOU
5 patentsUS8128922B2Mar 6, 2012
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
WU TZYY-CHOOU18 citations91
US9758551B2Sep 12, 2017
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
WU TZYY-CHOOU3 citations71
US9701725B2Jul 11, 2017
Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
WU TZYY-CHOOU2 citations71
US9085638B2Jul 21, 2015
DNA vaccine enhancement with MHC class II activators
WU TZYY-CHOOU4 citations71
US9011866B2Apr 21, 2015
RNA interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by DNA and transfected dendritic cell vaccines
WU TZYY-CHOOU4 citations71